Avidity Biosciences, Inc. Quarterly Debt-to-equity in % from Q1 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Avidity Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q1 2021 to Q2 2024.
  • Avidity Biosciences, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 14 %, a 31.5% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 14 +3.36 +31.5% Jun 30, 2024
Q1 2024 14.8 +3.34 +29.2% Mar 31, 2024
Q4 2023 13.6 +1.49 +12.3% Dec 31, 2023
Q3 2023 10.1 -2.62 -20.6% Sep 30, 2023
Q2 2023 10.7 -0.42 -3.79% Jun 30, 2023
Q1 2023 11.4 +0.93 +8.86% Mar 31, 2023
Q4 2022 12.1 +2.15 +21.6% Dec 31, 2022
Q3 2022 12.7 +3.64 +40.2% Sep 30, 2022
Q2 2022 11.1 +1.87 +20.3% Jun 30, 2022
Q1 2022 10.5 +1.86 +21.5% Mar 31, 2022
Q4 2021 9.94 Dec 31, 2021
Q3 2021 9.06 Sep 30, 2021
Q2 2021 9.2 Jun 30, 2021
Q1 2021 8.64 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.